AD mouse models APP/PSEN1 and PDAPP further revealed that cerebral levels of Aβ peptides and the deposition of plaques were significantly exacerbated in a SorLA concentration-dependent manner [187, 188]. This evidence concerns the gene SORL1 and Alzheimer disease.